EUVIMEDEUVIMED entdecken
Scoping ReviewOpen Access · CC BY-NC-ND 4.0

Movement Disorders Associated with 22q11.2 Microdeletion: A Scoping Review

Nikolai Gil D Reyes, Daniel G Di Luca, Connie Marras, Erik Boot, Ryan K C Yuen, Anthony E Lang, Anne S Bassett

Movement Disorders Clinical Practice · 2026-06 · 13 (6) · 1399-1417

DOI: 10.1002/mdc3.70459 ↗

Kurz gefasst

Scoping Review in der Zeitschrift Movement Disorders Clinical Practice, online erschienen am 03.12.2025. Verfasst von Nikolai Gil D Reyes und 6 weiteren Autor:innen. Beteiligte Einrichtung: Institute of Medical Science, Temerty Faculty of Medicine, University of Toronto, Toronto, Ontario, Canada. Hauptthemen laut MEDLINE: DiGeorge Syndrome, Movement Disorders. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 29 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Movement disorders have recently emerged as important neurologic manifestations of the 22q11.2 microdeletion that affects nearly one in every 2000 live births.

Objective

We aimed to map the existing evidence regarding the spectrum, diagnosis and treatment, and etiopathogenesis of movement disorders associated with 22q11.2 microdeletion, highlight key gaps, and provide recommendations for future research.

Methods

We conducted a comprehensive search of MEDLINE, Embase, CENTRAL, and reference lists to identify relevant clinical and preclinical studies, and summarize data on clinico‐pathologic features, risk factors, and pathophysiology of movement disorders associated with molecularly defined 22q11.2 microdeletions.

Results

Forty‐three (clinical: n = 41/43, 95%; preclinical: n = 2/43, 5%) studies met eligibility criteria. Most clinical studies (35/41, 85%) involved adults, of which 51% (21/41) were case series/reports, and the remainder observational studies. Key findings included: (1) emphasis on parkinsonism but emerging evidence for multiple other motor phenotypes, (2) non‐specific findings on routine neuroimaging, albeit with promising early results of certain modalities (eg, volumetric analyses, molecular imaging) and fluid‐based biomarkers, particularly for parkinsonism, and (3) multifaceted etiologic and pathophysiologic processes beyond those attributable to medication side effects. Prevailing gaps include research design limitations, heterogeneity of diagnostic methods, and limited systematic data on etiopathogenesis and treatments.

Conclusions

Current evidence supports an expanding spectrum of motor phenotypes associated with 22q11.2 microdeletion, with emerging data reporting potentially useful clinical markers and non‐drug‐related risk modifiers and underlying mechanisms. Addressing prevailing gaps will require enhanced research designs with up‐to‐date diagnostic and genetic methodologies, robust preclinical models, and cross‐disciplinary collaborations.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

DiGeorge SyndromeMovement DisordersHumansChromosome Deletion

Stichwörter der Autor:innen

22q11.2 deletion syndrome22q11.2 microdeletionmotor dysfunctionmovement disorder

Autor:innen und Institutionen

  • Institute of Medical Science, Temerty Faculty of Medicine, University of Toronto, Toronto, Ontario, Canada.
  • Edmond J. Safra Program in Parkinson's Disease, the Rossy Progressive Supranuclear Palsy Centre, and the Morton and Gloria Shulman Movement Disorders Clinic, Toronto Western Hospital, Toronto, Ontario, Canada.
  • Dalglish Family 22q Clinic, Toronto General Hospital, Toronto, Ontario, Canada.
  • Clinical Genetics Research Program, Centre for Addiction & Mental Health, Toronto, Ontario, Canada.
  • Department of Neurology, Washington University in St. Louis, St. Louis, Missouri, USA.
  • Advisium's Heeren Loo Zorggroep, Amersfoort, The Netherlands.

Zitieren

APA

Reyes, N. G. D., Di Luca, D. G., Marras, C., Boot, E., Yuen, R. K. C., Lang, A. E., & Bassett, A. S. (2026). Movement Disorders Associated with 22q11.2 Microdeletion: A Scoping Review. Movement Disorders Clinical Practice, 13(6), 1399-1417. https://doi.org/10.1002/mdc3.70459

Vancouver

Reyes NGD, Di Luca DG, Marras C, Boot E, Yuen RKC, Lang AE, et al. Movement Disorders Associated with 22q11.2 Microdeletion: A Scoping Review. Movement Disorders Clinical Practice. 2026;13(6):1399-1417. doi:10.1002/mdc3.70459

BibTeX
@article{Reyes2026,
  author = {Reyes, Nikolai Gil D and Di Luca, Daniel G and Marras, Connie and Boot, Erik and Yuen, Ryan K C and Lang, Anthony E and Bassett, Anne S},
  title = {Movement Disorders Associated with 22q11.2 Microdeletion: A Scoping Review},
  journal = {Movement Disorders Clinical Practice},
  year = {2026},
  volume = {13},
  number = {6},
  pages = {1399--1417},
  doi = {10.1002/mdc3.70459}
}
Kostenlos starten →